BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 72291)

  • 1. Secondary pituitary hyperplasia in Addison's disease.
    Clayton R; Burden AC; Schrieber V; Rosenthal FD
    Lancet; 1977 Nov; 2(8045):954-6. PubMed ID: 72291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease.
    Himsworth RL; Lewis JG; Rees LH
    Clin Endocrinol (Oxf); 1978 Aug; 9(2):131-9. PubMed ID: 212238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addison's Disease and Pituitary Enlargement.
    Winters SJ; Vitaz T; Nowacki MR; Craddock DC; Silverman C
    Am J Med Sci; 2015 Jun; 349(6):526-9. PubMed ID: 25004119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addison's disease in pregnancy: Case report, management, and review of the literature.
    Margulies SL; Corrigan K; Bathgate S; Macri C
    J Neonatal Perinatal Med; 2020; 13(2):275-278. PubMed ID: 31744021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary macroadenoma in Addison's disease.
    Akçay G; Aral F; Ozbey N; Azezli A; Orhan Y; Sencer E; Molvalilar S
    J Int Med Res; 1996; 24(2):221-7. PubMed ID: 8737233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to low-dose pulsatile cortisol in Addison's disease with suspected corticotropinoma.
    Carr DB; Fisher JE; Rosenblatt M
    Horm Metab Res; 1986 Aug; 18(8):569-73. PubMed ID: 3019857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging therapies for Addison's disease.
    Napier C; Pearce SH
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable ACTH-secreting pituitary tumour in association with Addison's disease.
    Yanase T; Sekiya K; Ando M; Nawata H; Kato K; Ibayashi H
    Acta Endocrinol (Copenh); 1985 Sep; 110(1):36-41. PubMed ID: 2994336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyper-adrenocorticotropinemia in a patient with Addison's disease after treatment with corticosteroids.
    Sugiyama K; Kimura M; Abe T; Ikezawa Y; Manaka H; Yamatani K; Tominaga M; Sasaki H; Misawa T
    Intern Med; 1996 Jul; 35(7):555-9. PubMed ID: 8842762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addison's disease, psychosis, and the syndrome of inappropriate secretion of antidiuretic hormone.
    Lever EG; Stansfeld SA
    Br J Psychiatry; 1983 Oct; 143():406-10. PubMed ID: 6414566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism and Addison's disease totally corrected by adrenal replacement therapy.
    Schwartz WL
    Calif Med; 1973 Feb; 118(2):57-60. PubMed ID: 4701710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of Addison's disease].
    Tiede N; Hofbauer LC; Bornstein SR; Kirch W
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1561-2. PubMed ID: 20665422
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible cardiomyopathy in paediatric Addison's disease--a cautionary tale.
    Conwell LS; Gray LM; Delbridge RG; Thomsett MJ; Batch JA
    J Pediatr Endocrinol Metab; 2003; 16(8):1191-5. PubMed ID: 14594181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pituitary tumour with possible ACTH and TSH hypersecretion in a patient with Addison's disease and primary hypothyroidism.
    Aanderud S; Bassøe HH
    Acta Endocrinol (Copenh); 1980 Oct; 95(2):181-4. PubMed ID: 6254305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
    Aanderud S; Myking OL; Bassøe HH
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):588-94. PubMed ID: 6289586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison's disease.
    Jara-Albarran A; Bayort J; Caballero A; Portillo J; Laborda L; Sampedro M; Cure C; Mateos JM
    J Clin Endocrinol Metab; 1979 Aug; 49(2):236-41. PubMed ID: 222793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addison's disease.
    Nieman LK; Chanco Turner ML
    Clin Dermatol; 2006; 24(4):276-80. PubMed ID: 16828409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid replacement in Addison's disease.
    Thompson DG; Mason AS; Goodwin FJ
    Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudotumor cerebri: a presenting manifestation of Addison's disease.
    Condulis N; Germain G; Charest N; Levy S; Carpenter TO
    Clin Pediatr (Phila); 1997 Dec; 36(12):711-3. PubMed ID: 9415840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.